Dr. Alqahtani is currently the Chairman and CEO of the Royal Clinics in Saudi Arabia, a Professor of Medicine at Alfaisal University, Riyadh, Saudi Arabia and an Associate Professor of Medicine at Weill Cornell Medicine, New York, USA. Prior to joining the Royal Clinics, he was the Medical Director of International Digestive and Liver Services at Johns Hopkins Hospital, USA. Dr. Alqahtani earned his medical degree from the King Abdulaziz University, Saudi Arabia and completed his postgraduate training in gastroenterology at the University of Calgary, Canada, followed by an advanced Liver Disease fellowship at the Mayo Clinic, USA.
Dr. Alqahtani is the recipient of several awards and honors and serves as a member on editorial and advisory boards. He has published extensively in peer-reviewed journals, authored book chapters and is an expert in liver, digestive diseases and endoscopy. He has been the principal investigator of clinical trials related to the management of viral hepatitis and fatty liver disease, including novel agents, and the co-investigator for clinical trials in liver cancer, liver cirrhosis and outcome of liver transplantation. He is an invited speaker at scientific conferences in the United States, Middle East, Latin America, Asia and Europe.
Dr. Alqahtani is certified by the American Board of Internal Medicine in Gastroenterology, Transplant Hepatology and Obesity Medicine, and is a member of professional societies including the American College of Gastroenterology, the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, the Global NASH Council, the Mayo Clinic Alumni Association, and the Johns Hopkins Alumni Association.
